Professional Documents
Culture Documents
Ants
Adrián A. Pinto-Tomás, et al.
Science 326, 1120 (2009);
DOI: 10.1126/science.1173036
If you wish to distribute this article to others, you can order high-quality copies for your
colleagues, clients, or customers by clicking here.
Permission to republish or repurpose articles or portions of articles can be obtained by
following the guidelines here.
Science (print ISSN 0036-8075; online ISSN 1095-9203) is published weekly, except the last week in December, by the
American Association for the Advancement of Science, 1200 New York Avenue NW, Washington, DC 20005. Copyright
2009 by the American Association for the Advancement of Science; all rights reserved. The title Science is a
registered trademark of AAAS.
REPORTS
34. We thank S. Hargreaves, M. Smith, M. Wilkening, sequencing data are available at the National Center for Figs. S1 to S6
T. Kemmerer, P. Lu, C.-T. Yeh, and L. Coffey for sample Biotechnology Information GEO database in series GSE16136. Tables S1 to S9
and data processing and the maize genome sequence References
project (NSF DBI-0527192) for sharing genome sequences Supporting Online Material
before publication. Funding provided by Iowa State www.sciencemag.org/cgi/content/full/326/5956/1118/DC1 26 June 2009; accepted 15 October 2009
University’s Plant Sciences Institute. Microarray and Materials and Methods 10.1126/science.1178294
M
Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
4
of HIV-1, an effective vaccine remains broadly neutralizing antibodies in humans. The Center for Cancer Research, National Cancer Institute,
Frederick, MD 21702, USA. 5Laboratory of Immunoregulation,
elusive. In this time, an estimated 60 site of vulnerability corresponds to the initial site National Institute of Allergy and Infectious Diseases, National
million individuals have been infected by HIV- of attachment between gp120 on the viral spike Institutes of Health, Bethesda, MD 20892, USA. 6Ragon
1, and ~20 million have died (1). Identification and the CD4 receptor on the host cell. However, Institute of Massachusetts General Hospital, Massachusetts
of a site on the HIV-1 gp120 envelope glyco- most CD4–binding site (CD4BS) antibodies do Institute of Technology and Harvard University, Boston, MA
protein that is vulnerable to neutralizing anti- not effectively neutralize HIV-1 (8–10). 02114, USA. 7Department of Cancer Immunology and AIDS,
Dana-Farber Cancer Institute, Harvard Medical School, Boston,
bodies (2), along with the discovery that a major The HIV-1 gp120 envelope glycoprotein con- MA 02115, USA.
subpopulation of individuals infected with HIV-1 tains a number of features that help evade hu- *These authors contributed equally to this work.
develops broadly effective antibodies against moral immunity, including variable loops (11), †To whom correspondence should be addressed. E-mail:
this site (3–7), has provided both a vaccine tar- N-linked glycosylation (12, 13), and conforma- pdkwong@nih.gov